MHRA data requirements to support regulatory decision making
A regulator’s view on what the new UK Health Data Research Service must deliver.
Documents
Details
The purpose of this paper is to outline the Medicines and Healthcare Products Regulatory Agency’s (MHRA) data needs and use cases, focusing on the limitations of the current UK data landscape and how this a future Health Data Research Service (HDRS) could address these gaps.